Advent Pharma Ltd. (DSE:ADVENT)

Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
14.20
+0.10 (0.71%)
At close: Feb 26, 2026
-11.80%
Market Cap 1.32B
Revenue (ttm) 516.48M
Net Income (ttm) 57.23M
Shares Out 93.13M
EPS (ttm) 0.62
PE Ratio 22.96
Forward PE n/a
Dividend 0.05 (0.35%)
Ex-Dividend Date Nov 23, 2025
Volume 126,138
Average Volume 224,944
Open 14.10
Previous Close 14.10
Day's Range 14.00 - 14.20
52-Week Range 11.50 - 17.30
Beta 0.40
RSI 57.41
Earnings Date Apr 29, 2026

About Advent Pharma

Advent Pharma Ltd., a pharmaceutical company, manufactures, imports, and markets animal health care drugs, nutritional supplements, and feed additives for livestock in Bangladesh. The company offers poultry, aquaculture, and cattle products. It provides its products in powder, bolus, and liquid dosage forms. It offers Yea-Sacc Bolus, Bioplex Dairy Max Bolus, SUPERIOR SYN BIOTECH, Oxi-D Bolus, and TOXOSORB. Advent Pharma Ltd. was incorporated in 2007 and is based in Dhaka, Bangladesh. [Read more]

Industry Pharmaceutical Preparations
Founded 2007
Employees 317
Stock Exchange Dhaka Stock Exchange
Ticker Symbol ADVENT
Full Company Profile

Financial Performance

In fiscal year 2025, Advent Pharma's revenue was 500.49 million, a decrease of -12.45% compared to the previous year's 571.67 million. Earnings were 66.87 million, a decrease of -20.38%.

Financial Statements

News

There is no news available yet.